Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C19H20F3NO |
| Molecular Weight | 335.3634 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
FC(F)(F)C1=CC=C(C=C1)C2=CC=C(OCCN3CCCC3)C=C2
InChI
InChIKey=FOCUKKUAGZPPCU-UHFFFAOYSA-N
InChI=1S/C19H20F3NO/c20-19(21,22)17-7-3-15(4-8-17)16-5-9-18(10-6-16)24-14-13-23-11-1-2-12-23/h3-10H,1-2,11-14H2
| Molecular Formula | C19H20F3NO |
| Molecular Weight | 335.3634 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
DescriptionSources: https://www.ncbi.nlm.nih.gov/pubmed/28642035
Sources: https://www.ncbi.nlm.nih.gov/pubmed/28642035
Boxidine (1-[2-[[4′-(Trifluoromethyl)-4-biphenylyl]oxy]ethyl]pyrrolidine) is an inhibitor of 3β-hydroxysteroid-Δ7-reductase (DHCR7) thereby it affects cholesterol biosynthesis. Boxidine induces the accumulation of desmosterol.
Approval Year
| Substance Class |
Chemical
Created
by
admin
on
Edited
Wed Apr 02 09:30:38 GMT 2025
by
admin
on
Wed Apr 02 09:30:38 GMT 2025
|
| Record UNII |
8MJ40K4117
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Preferred Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C29703
Created by
admin on Wed Apr 02 09:30:38 GMT 2025 , Edited by admin on Wed Apr 02 09:30:38 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
100000088657
Created by
admin on Wed Apr 02 09:30:38 GMT 2025 , Edited by admin on Wed Apr 02 09:30:38 GMT 2025
|
PRIMARY | |||
|
C100055
Created by
admin on Wed Apr 02 09:30:38 GMT 2025 , Edited by admin on Wed Apr 02 09:30:38 GMT 2025
|
PRIMARY | |||
|
31742
Created by
admin on Wed Apr 02 09:30:38 GMT 2025 , Edited by admin on Wed Apr 02 09:30:38 GMT 2025
|
PRIMARY | |||
|
DTXSID70145896
Created by
admin on Wed Apr 02 09:30:38 GMT 2025 , Edited by admin on Wed Apr 02 09:30:38 GMT 2025
|
PRIMARY | |||
|
2392
Created by
admin on Wed Apr 02 09:30:38 GMT 2025 , Edited by admin on Wed Apr 02 09:30:38 GMT 2025
|
PRIMARY | |||
|
C91025
Created by
admin on Wed Apr 02 09:30:38 GMT 2025 , Edited by admin on Wed Apr 02 09:30:38 GMT 2025
|
PRIMARY | |||
|
SUB05879MIG
Created by
admin on Wed Apr 02 09:30:38 GMT 2025 , Edited by admin on Wed Apr 02 09:30:38 GMT 2025
|
PRIMARY | |||
|
CHEMBL1615348
Created by
admin on Wed Apr 02 09:30:38 GMT 2025 , Edited by admin on Wed Apr 02 09:30:38 GMT 2025
|
PRIMARY | |||
|
10355-14-3
Created by
admin on Wed Apr 02 09:30:38 GMT 2025 , Edited by admin on Wed Apr 02 09:30:38 GMT 2025
|
PRIMARY | |||
|
8MJ40K4117
Created by
admin on Wed Apr 02 09:30:38 GMT 2025 , Edited by admin on Wed Apr 02 09:30:38 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
SALT/SOLVATE -> PARENT |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |